Tekla Healthcare Investors
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | -9.7% | +5.7% | +1.7% | -19.1% | +20.3% | +11.1% | -21.0% | +0.7% | +13.8% | +3.4% | |
| – | +40.1% | -4.8% | -43.1% | -43.8% | +46.9% | -75.0% | +81.4% | +244.4% | -7.2% | -98.5% | +332.9% | |
| – | +18,543.0% | -99.6% | +731,072.1% | -100.0% | +178,273.8% | -249.0% | – | -15.3% | -73.0% | -73.8% | +5.4% | |
| – | +18,543.0% | -99.6% | +731,072.1% | -100.0% | +178,273.8% | +49.0% | -100.0% | -15.3% | -73.0% | -73.8% | +5.4% | |
| – | -73.9% | +403.3% | -98.1% | +148.6% | +1,864.6% | -52.1% | -6.4% | -29.1% | +139.0% | -92.8% | +412.2% | |
| – | – | – | – | – | – | – | – | +116.1% | -100.0% | – | – | |
| – | +1,108.5% | +153.9% | -71.9% | -61.5% | +84.5% | -83.8% | +1,291.5% | -37.9% | -88.2% | +21.5% | +145.8% | |
| – | +1,108.5% | +153.9% | -71.9% | -61.5% | +84.5% | -84.2% | +1,331.5% | -37.9% | -88.2% | +21.5% | -13.1% | |
| – | – | – | – | – | – | – | +35,990.2% | -25.0% | – | – | – | |
| – | – | +175.7% | -74.4% | -69.8% | +129.0% | – | – | – | – | – | – | |
| – | +4.9% | -11.7% | +8.5% | +2.3% | -19.5% | +21.1% | +9.7% | -20.8% | +1.6% | +13.8% | +3.2% | |
| – | +0.3% | -39.5% | +17.5% | -3.5% | -74.9% | +220.6% | +26.5% | -91.8% | -75.9% | +1,875.0% | -13.9% | |
| – | +4.1% | +4.6% | +4.2% | +3.9% | +1.4% | +2.4% | +3.5% | +4.2% | +4.4% | +5.4% | +2.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.